Nanoparticles as targeting ligands

被引：21

作者：

Jain, KK ^{[1
]}

机构：

[1] Jain PharmaBiotech, CH-4057 Basel, Switzerland

来源：

TRENDS IN BIOTECHNOLOGY | 2006年 / 24卷 / 04期

关键词：

D O I：

10.1016/j.tibtech.2006.02.004

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

A recently published technique enables the attachment of small molecules to nanoparticles for improved targeting of nanomaterials. This new methodology has been compared with some of the other nanoparticle-based techniques for target discovery and found to be more versatile and specific. This approach has potential for high-throughput drug discovery, improved drug delivery and linking of diagnostics to therapeutics for the development of personalized medicines.

引用

收藏

页码：143 / 145

页数：3

相关论文

共 11 条

[1] Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes [J].

Balthasar, S ;

Michaelis, K ;

Dinauer, N ;

von Briesen, H ;

Kreuter, J ;

Langer, K .

BIOMATERIALS, 2005, 26 (15) :2723-2732

[2] Targeting cancer cells with DNA-Assembled dendrimers - A mix and match strategy for cancer [J].

Choi, Y ;

Baker, JR .

CELL CYCLE, 2005, 4 (05) :669-671

[3] Highly efficient multiphoton-absorption-induced luminescence from gold nanoparticles [J].

Farrer, RA ;

Butterfield, FL ;

Chen, VW ;

Fourkas, JT .

NANO LETTERS, 2005, 5 (06) :1139-1142

[4] The role of nanobiotechnology in drug discovery [J].

Jain, KK .

DRUG DISCOVERY TODAY, 2005, 10 (21) :1435-1442

[5] Transport of surface-modified nanoparticles through cell monolayers [J].

Koch, AM ;

Reynolds, F ;

Merkle, HR ;

Weissleder, R ;

Josephson, L .

CHEMBIOCHEM, 2005, 6 (02) :337-345

[6] Surface modification of poly(lactic acid) nanoparticles by covalent attachment of thiol groups by means of three methods [J].

Nobs, L ;

Buchegger, F ;

Gurny, R ;

Allémann, E .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 250 (02) :327-337

[7] Quantum dots and other nanoparticles: what can they offer to drug discovery? [J].

Ozkan, M .

DRUG DISCOVERY TODAY, 2004, 9 (24) :1065-1071

[8] Nanobodies as novel agents for cancer therapy [J].

Revets, H ;

De Baetselier, P ;

Muyldermans, S .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (01) :111-124

[9] Non-covalent polyvalent ligands by self-assembly of small glycodendrimers: A novel concept for the inhibition of polyvalent carbohydrate-protein interactions in vitro and in vivo [J].

Thoma, G ;

Streiff, MB ;

Katopodis, AG ;

Duthaler, RO ;

Voelcker, NH ;

Ehrhardt, C ;

Masson, C .

CHEMISTRY-A EUROPEAN JOURNAL, 2006, 12 (01) :99-117

[10] Cell-specific targeting of nanoparticles by multivalent attachment of small molecules [J].

Weissleder, R ;

Kelly, K ;

Sun, EY ;

Shtatland, T ;

Josephson, L .

NATURE BIOTECHNOLOGY, 2005, 23 (11) :1418-1423